Recall Enforment Report D-0064-2023
Multi event Drug Recall Enforcement Report Class II voluntary initiated by Nephron Sterile Compounding Center LLC, originally initiated on 11-10-2022 for the product PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-946-34, UPC 3 69374 94634 6. The product was recalled due to cgmp deviations: potential for cross contamination due to product carry over.. The product was distributed nationwide and the recall is currently ongoing.
Recall Enforcement Reports
Recall Number | Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-0064-2023 | 11-10-2022 | 11-23-2022 | Class II | 34,020 vials | PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-946-34, UPC 3 69374 94634 6. | CGMP Deviations: Potential for cross contamination due to product carry over. | Ongoing |
D-0065-2023 | 11-10-2022 | 11-23-2022 | Class II | 56,220 vials | PF-Neostigmine Methylsulfate Injection, USP 3 mg/3 mL (1 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-932-33, UPC 3 69374-93233 2. | CGMP Deviations: Potential for cross contamination due to product carry over. | Ongoing |